|
Index of reports
> Cases with White Blood Cell Count Decreased (28)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Gemzar (Gemcitabine) where reactions include white blood cell count decreased. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Gemzar side effects in male
Reported by a consumer/non-health professional from Japan on 2012-08-27
Patient: male, weighing 80.0 kg (176.0 pounds)
Reactions: Off Label Use, White Blood Cell Count Decreased, Neoplasm Progression, Metastases To Bone, Nephrotic Syndrome, Acute Prerenal Failure
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Alimta
Dosage: 750 mg, every 3 weeks
Indication: Pleural Mesothelioma Malignant
Start date: 2009-03-12
End date: 2009-09-24
Gemzar
Dosage: unk
Start date: 2010-05-28
End date: 2010-06-04
Other drugs received by patient: Amlodipine; Vitamin B12; Panvitan; Calblock; Amlodipine; Cisplatin
Possible Gemzar side effects in female
Reported by a physician from Japan on 2012-08-16
Patient: female, weighing 42.0 kg (92.4 pounds)
Reactions: Haemoglobin Decreased, White Blood Cell Count Decreased, Nausea, Platelet Count Decreased, Decreased Appetite
Drug(s) suspected as cause:
Gemzar
Dosage: 1500 mg, other
Indication: Gallbladder Cancer Stage IV
Start date: 2011-07-25
End date: 2011-08-29
Gemzar
Dosage: 1300 mg, unk
Start date: 2011-10-10
End date: 2011-12-05
Other drugs received by patient: Cisplatin; Cisplatin
Possible Gemzar side effects in 74 year old female
Reported by a consumer/non-health professional from Japan on 2012-07-11
Patient: 74 year old female
Reactions: White Blood Cell Count Decreased, Nausea, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Gemzar
Dosage: 1300 mg, unk
End date: 2011-12-05
Gemzar
Dosage: 1500 mg, other
Indication: Gallbladder Cancer Stage IV
Start date: 2011-07-25
End date: 2011-08-15
Other drugs received by patient: Cisplatin; Cisplatin
Possible Gemzar side effects in female
Reported by a physician from Japan on 2012-07-10
Patient: female, weighing 52.0 kg (114.4 pounds)
Reactions: Dermatitis Acneiform, Paronychia, White Blood Cell Count Decreased, Stomatitis, Alanine Aminotransferase Increased, Pyrexia, Diarrhoea, Interstitial Lung Disease, Aspartate Aminotransferase Increased, Platelet Count Decreased, Neutrophil Count Decreased, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Gemzar
Dosage: 1000 mg/m2, weekly
Indication: Adenocarcinoma Pancreas
Start date: 2011-09-30
End date: 2011-10-07
Gemzar
Dosage: 1000 mg/m2, weekly
Start date: 2011-11-14
End date: 2011-11-28
Gemzar
Dosage: 1000 mg/m2, weekly
Start date: 2011-10-24
End date: 2011-10-31
Tarceva
Dosage: 100 mg, uid/qd
Administration route: Oral
Indication: Adenocarcinoma Pancreas
Start date: 2011-09-30
End date: 2011-12-09
Other drugs received by patient: Rabeprazole Sodium; Levofloxacin; Sennoside / 00571901 /; Rebamipide; Magmitt; Loxoprofen; Goodmin
Possible Gemzar side effects in male
Reported by a consumer/non-health professional from United States on 2012-07-03
Patient: male
Reactions: White Blood Cell Count Decreased, Neoplasm Malignant, Immunosuppression
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Gemzar
Other drugs received by patient: Carboplatin
Possible Gemzar side effects in female
Reported by a consumer/non-health professional from Japan on 2012-06-25
Patient: female, weighing 60.0 kg (132.0 pounds)
Reactions: White Blood Cell Count Decreased, Colitis Ischaemic, Platelet Count Decreased, Constipation
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Gemzar
Dosage: 1600 mg, other
Indication: Gallbladder Cancer Stage IV
Start date: 2012-03-06
End date: 2012-03-13
Gemzar
Dosage: 1000 mg, other
Start date: 2012-05-24
End date: 2012-05-24
Other drugs received by patient: Decadron / 00016002 /; Aloxi; Emend; Cisplatin; Cisplatin; Norvasc
Possible Gemzar side effects in 68 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-04-11
Patient: 68 year old female
Reactions: White Blood Cell Count Decreased, Anaemia, Neutrophil Count Decreased, Disease Progression
Drug(s) suspected as cause:
Gemzar
Indication: Ovarian Cancer
Hycamtin
Dosage: 1.5mgm2 per day
Indication: Ovarian Cancer
Start date: 2011-09-05
End date: 2011-12-17
Possible Gemzar side effects in male
Reported by a physician from Japan on 2012-04-11
Patient: male, weighing 65.0 kg (143.0 pounds)
Reactions: Pruritus Generalised, White Blood Cell Count Decreased, Interstitial Lung Disease, Cerebral Infarction, Dehydration
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Gemzar
Dosage: 1600 mg, other/day one, eight and 15
Indication: Pancreatic Carcinoma Stage IV
Start date: 2011-09-08
End date: 2011-11-24
Gemzar
Dosage: 1600 mg, other/ every other week
Start date: 2011-12-08
End date: 2011-12-22
Other drugs received by patient: TS 1
Possible Gemzar side effects in male
Reported by a physician from Japan on 2012-03-30
Patient: male, weighing 60.4 kg (132.9 pounds)
Reactions: White Blood Cell Count Decreased, Interstitial Lung Disease, Respiratory Failure
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Gemzar
Dosage: unk
Indication: Transitional Cell Carcinoma
Start date: 2009-06-30
End date: 2009-11-21
Gemzar
Dosage: 1600 mg, unk
Start date: 2010-01-08
End date: 2010-02-18
Other drugs received by patient: Decadron; Daikentyuto; Paclitaxel; Lansoprazole; Granisetron; Zantac; Basen; Oxycontin; Restamin; Cisplatin; Clonazepam
Possible Gemzar side effects in male
Reported by a consumer/non-health professional from Japan on 2012-03-14
Patient: male, weighing 60.4 kg (132.9 pounds)
Reactions: White Blood Cell Count Decreased, Interstitial Lung Disease, Respiratory Failure
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Gemzar
Dosage: 1600 mg, unk
Start date: 2010-01-08
End date: 2010-02-18
Gemzar
Dosage: unk
Indication: Transitional Cell Carcinoma
Start date: 2009-06-30
End date: 2009-11-21
Other drugs received by patient: Restamin; Daikentyuto; Cisplatin; Basen; Clonazepam; Paclitaxel; Decadron; Zantac; Granisetron; Lansoprazole; Oxycontin
Possible Gemzar side effects in male
Reported by a consumer/non-health professional from Japan on 2012-03-13
Patient: male, weighing 65.0 kg (143.0 pounds)
Reactions: Pruritus Generalised, White Blood Cell Count Decreased, Cerebral Infarction, Interstitial Lung Disease
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Gemzar
Dosage: 1600 mg, other/day one, eight and 15
Indication: Pancreatic Carcinoma Stage IV
Start date: 2011-09-08
End date: 2011-11-24
Gemzar
Dosage: 1600 mg, other/ every other week
Start date: 2011-12-08
End date: 2011-12-22
Other drugs received by patient: TS 1
Possible Gemzar side effects in 67 year old male
Reported by a consumer/non-health professional from Japan on 2012-03-08
Patient: 67 year old male
Reactions: White Blood Cell Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Gemzar
Zolpidem
Administration route: Oral
Indication: Insomnia
Start date: 2012-01-28
Other drugs received by patient: Insulin; Lansoprazole
Possible Gemzar side effects in female
Reported by a physician from Japan on 2012-03-01
Patient: female, weighing 49.0 kg (107.8 pounds)
Reactions: White Blood Cell Count Decreased, Nasopharyngitis, Rash, Oropharyngeal Pain, Diarrhoea, C-Reactive Protein Increased, Cholangitis, Insomnia
Drug(s) suspected as cause:
Erlotinib Hydrochloride
Dosage: 100 mg, uid/qd
Administration route: Oral
Indication: Adenocarcinoma Pancreas
Start date: 2011-09-06
Gemzar
Dosage: unk
Indication: Adenocarcinoma Pancreas
Start date: 2011-07-19
End date: 2011-08-23
Gemzar
Dosage: 1100 mg/m2, uid/qd
Start date: 2011-10-06
End date: 2011-10-06
Gemzar
Dosage: 1000 mg/m2, uid/qd
Start date: 2011-11-17
End date: 2011-11-17
Gemzar
Dosage: 1100 mg/m2, uid/qd
Start date: 2011-10-13
End date: 2011-10-13
Gemzar
Dosage: 800 mg/m2, uid/qd
Start date: 2011-12-01
End date: 2011-12-01
Gemzar
Dosage: 800 mg/m2, uid/qd
Start date: 2012-01-12
End date: 2012-01-12
Gemzar
Dosage: 1100 mg/m2, uid/qd
Start date: 2011-11-04
End date: 2011-11-04
Gemzar
Dosage: 800 mg/m2, uid/qd
Start date: 2012-01-05
End date: 2012-01-05
Gemzar
Dosage: 600 mg/m2, uid/qd
Start date: 2012-01-19
Gemzar
Dosage: 1100 mg/m2, uid/qd
Start date: 2011-10-20
End date: 2011-10-20
Gemzar
Dosage: 1100 mg/m2, uid/qd
Start date: 2011-11-10
End date: 2011-11-10
Gemzar
Dosage: 800 mg/m2, uid/qd
Start date: 2011-12-15
End date: 2011-12-15
Gemzar
Dosage: 1100 mg/m2, weekly x 3 wks
Start date: 2011-09-06
End date: 2011-09-20
Other drugs received by patient: Naproxen; Furosemide; Lexotan; Lexotan; Lansoprazole; Oxycontin; Trimebutine Maleate; Toughmac E; Primperan TAB; Urso 250; Miya BM
Possible Gemzar side effects in male
Reported by a consumer/non-health professional from Japan on 2012-02-27
Patient: male, weighing 60.4 kg (132.9 pounds)
Reactions: White Blood Cell Count Decreased, Interstitial Lung Disease, Respiratory Failure
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Gemzar
Dosage: unk
Indication: Transitional Cell Carcinoma
Start date: 2009-06-30
End date: 2009-11-21
Gemzar
Dosage: 1600 mg, unk
Start date: 2010-01-08
End date: 2010-02-18
Other drugs received by patient: Cisplatin; Daikentyuto; Clonazepam; Paclitaxel; Basen; Granisetron; Lansoprazole; Restamin; Zantac; Oxycontin; Decadron
Possible Gemzar side effects in female
Reported by a physician from Japan on 2012-02-23
Patient: female, weighing 49.0 kg (107.8 pounds)
Reactions: White Blood Cell Count Decreased, Nasopharyngitis, Rash, Oropharyngeal Pain, C-Reactive Protein Increased, Diarrhoea, Insomnia, Cholangitis
Drug(s) suspected as cause:
Erlotinib Hydrochloride
Dosage: 100 mg, uid/qd
Administration route: Oral
Indication: Adenocarcinoma Pancreas
Start date: 2011-09-06
Gemzar
Dosage: 1100 mg/m2, weekly x 3 wks
Start date: 2011-09-06
End date: 2011-09-20
Gemzar
Dosage: 800 mg/m2, uid/qd
Start date: 2011-12-15
End date: 2011-12-15
Gemzar
Dosage: 800 mg/m2, uid/qd
Start date: 2012-01-12
End date: 2012-01-12
Gemzar
Dosage: 1100 mg/m2, uid/qd
Start date: 2011-11-10
End date: 2011-11-10
Gemzar
Dosage: 1100 mg/m2, uid/qd
Start date: 2011-11-04
End date: 2011-11-04
Gemzar
Dosage: 1000 mg/m2, uid/qd
Start date: 2011-11-17
End date: 2011-11-17
Gemzar
Dosage: 800 mg/m2, uid/qd
Start date: 2012-01-05
End date: 2012-01-05
Gemzar
Dosage: 1100 mg/m2, uid/qd
Start date: 2011-10-20
End date: 2011-10-20
Gemzar
Dosage: 1100 mg/m2, uid/qd
Start date: 2011-10-06
End date: 2011-10-06
Gemzar
Dosage: 1100 mg/m2, uid/qd
Start date: 2011-10-13
End date: 2011-10-13
Gemzar
Dosage: unk
Indication: Adenocarcinoma Pancreas
Start date: 2011-07-19
End date: 2011-08-23
Gemzar
Dosage: 800 mg/m2, uid/qd
Start date: 2011-12-01
End date: 2011-12-01
Gemzar
Dosage: 600 mg/m2, uid/qd
Start date: 2012-01-19
Other drugs received by patient: Furosemide; Toughmac E; Primperan TAB; Urso 250; Oxycontin; Trimebutine Maleate; Lexotan; Miya BM; Naproxen; Lansoprazole; Lexotan
Possible Gemzar side effects in 67 year old male
Reported by a consumer/non-health professional from Japan on 2012-02-23
Patient: 67 year old male
Reactions: White Blood Cell Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Gemzar
Zolpidem
Administration route: Oral
Indication: Insomnia
Start date: 2012-01-28
Other drugs received by patient: Lansoprazole; Insulin
Possible Gemzar side effects in male
Reported by a physician from Japan on 2012-02-20
Patient: male, weighing 65.0 kg (143.0 pounds)
Reactions: White Blood Cell Count Decreased, Pruritus Generalised, Interstitial Lung Disease, Cerebral Infarction
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Gemzar
Dosage: 1600 mg, other/ every other week
Start date: 2011-12-08
End date: 2011-12-22
Gemzar
Dosage: 1600 mg, other/day one, eight and 15
Indication: Pancreatic Carcinoma Stage IV
Start date: 2011-09-08
End date: 2011-11-24
Other drugs received by patient: TS 1
Possible Gemzar side effects in 80 year old male
Reported by a physician from Japan on 2012-01-30
Patient: 80 year old male
Reactions: White Blood Cell Count Decreased, Pneumonia, Hepatic Atrophy
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Gemzar
Dosage: unk
Indication: Bile Duct Cancer Recurrent
Start date: 2011-01-01
Gemzar
Dosage: unk, 2/m
End date: 2011-05-01
Possible Gemzar side effects in female
Reported by a physician from Japan on 2012-01-03
Patient: female, weighing 49.0 kg (107.8 pounds)
Reactions: White Blood Cell Count Decreased, C-Reactive Protein Increased, Diarrhoea, Cholangitis, Rash
Drug(s) suspected as cause:
Erlotinib Hydrochloride
Dosage: 100 mg, uid/qd
Administration route: Oral
Indication: Adenocarcinoma Pancreas
Start date: 2011-09-06
Gemzar
Dosage: 1100 mg/m2, uid/qd
Start date: 2011-10-06
End date: 2011-10-06
Gemzar
Dosage: 1100 mg/m2, uid/qd
Start date: 2011-10-20
End date: 2011-10-20
Gemzar
Dosage: 1000 mg/m2, uid/qd
Start date: 2011-11-17
Gemzar
Dosage: 1100 mg/m2, weekly x 3 wks
Start date: 2011-09-06
End date: 2011-09-20
Gemzar
Dosage: 1100 mg/m2, uid/qd
Start date: 2011-10-13
End date: 2011-10-13
Gemzar
Dosage: unk
Indication: Adenocarcinoma Pancreas
Start date: 2011-07-19
End date: 2011-08-23
Gemzar
Dosage: 1100 mg/m2, uid/qd
Start date: 2011-11-04
End date: 2011-11-04
Gemzar
Dosage: 1100 mg/m2, uid/qd
Start date: 2011-11-10
End date: 2011-11-10
Other drugs received by patient: Furosemide; Urso 250; Toughmac E; Primperan TAB; Miya BM; Lexotan; Trimebutine Maleate; Lexotan; Naproxen; Oxycontin; Lansoprazole
Possible Gemzar side effects in female
Reported by a consumer/non-health professional from Japan on 2011-12-22
Patient: female, weighing 70.0 kg (154.0 pounds)
Reactions: White Blood Cell Count Decreased, Hypersensitivity, Shock Haemorrhagic, Pleural Effusion, Haemolytic Uraemic Syndrome, Pleural Haemorrhage
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Gemzar
Dosage: 1500 mg, other
Indication: Ovarian Cancer Recurrent
Start date: 2008-04-11
End date: 2008-08-01
Gemzar
Dosage: 1000 mg, other
Start date: 2008-08-22
End date: 2008-12-19
Other drugs received by patient: Carboplatin; Loxonin; Vasolax; Selbex; Acetaminophen; Primperan / 00041901 /
Possible Gemzar side effects in female
Reported by a physician from Japan on 2011-12-14
Patient: female, weighing 52.0 kg (114.4 pounds)
Reactions: White Blood Cell Count Decreased, Anaemia, Platelet Count Decreased, Intestinal Obstruction, Erythropenia, Ovarian Cancer
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Doxorubicin HCL
Dosage: cycle 6
Indication: Ovarian Cancer Recurrent
Start date: 2009-10-13
End date: 2009-10-13
Doxorubicin HCL
Dosage: cycle 5
Start date: 2009-09-02
End date: 2009-09-02
Doxorubicin HCL
Dosage: cycle 3
Start date: 2009-06-26
End date: 2009-06-26
Doxorubicin HCL
Dosage: cycle 11
Start date: 2010-03-01
End date: 2010-03-01
Doxorubicin HCL
Dosage: cycle 4
Start date: 2009-08-05
End date: 2009-08-05
Doxorubicin HCL
Dosage: cycle 7
Start date: 2009-11-01
End date: 2009-11-01
Doxorubicin HCL
Dosage: cycle 8
Start date: 2009-12-01
End date: 2009-12-01
Doxorubicin HCL
Dosage: cycle 9
Start date: 2010-01-01
End date: 2010-01-01
Doxorubicin HCL
Start date: 2009-04-28
End date: 2009-04-28
Doxorubicin HCL
Dosage: cycle 10
Start date: 2010-02-01
End date: 2010-02-01
Doxorubicin HCL
Start date: 2009-05-27
End date: 2009-05-27
Doxorubicin HCL
Dosage: cycle 12
Start date: 2010-03-01
End date: 2010-03-01
Gemzar
Indication: Ovarian Cancer Recurrent
Start date: 2008-10-29
End date: 2010-10-13
Oxaliplatin
Indication: Ovarian Cancer Recurrent
Start date: 2008-10-01
End date: 2010-10-13
Other drugs received by patient: Neutrogin; TPN; Primperan TAB; Primperan TAB; Gasmotin; Motilium; TPN; Concentrated Human RED Blood Cells; Celecoxib; DAI-Kenchu-TO; Dacarbazine; Concentrated Human RED Blood Cells; Concentrated Human RED Blood Cells; Primperan TAB; Motilium; Pydoxal; TPN; Concentrated Human RED Blood Cells; Lansoprazole
Possible Gemzar side effects in male
Reported by a consumer/non-health professional from United States on 2011-12-01
Patient: male
Reactions: Weight Decreased, Haemoglobin Decreased, Dysgeusia, White Blood Cell Count Decreased, Diarrhoea, Alopecia, Rash, Constipation, Eating Disorder
Drug(s) suspected as cause:
Gemzar
Other drugs received by patient: Tarceva
Possible Gemzar side effects in male
Reported by a consumer/non-health professional from Japan on 2011-11-22
Patient: male, weighing 80.0 kg (176.0 pounds)
Reactions: White Blood Cell Count Decreased, Off Label Use, Neoplasm Progression, Metastases To Bone, Acute Prerenal Failure, Nephrotic Syndrome
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Alimta
Dosage: 750 mg, every 3 weeks
Indication: Pleural Mesothelioma Malignant
Start date: 2009-03-12
End date: 2009-09-24
Gemzar
Dosage: unk
Start date: 2010-05-28
End date: 2010-06-04
Other drugs received by patient: Calblock; Panvitan; Cisplatin; Methycobal; Amlodipine; Amlodipine
Possible Gemzar side effects in female
Reported by a consumer/non-health professional from United States on 2011-11-17
Patient: female
Reactions: Weight Decreased, White Blood Cell Count Decreased, Aphagia, Oral Pain, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Gemzar
Dosage: 1500 mg, other
Start date: 2011-11-09
Gemzar
Dosage: 2000 mg, other
Indication: Breast Cancer Recurrent
Start date: 2011-10-17
Other drugs received by patient: Taxotere; Taxotere; Percocet
Possible Gemzar side effects in 63 year old male
Reported by a consumer/non-health professional from United States on 2011-11-02
Patient: 63 year old male, weighing 82.0 kg (180.4 pounds)
Reactions: White Blood Cell Count Decreased, Platelet Count Decreased, Gastroduodenal Ulcer
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cisplatin
Dosage: last dose on 24mar2011-24mar11=1day interrupted on 13apr2011,resumed on 27apr11 with dose reduced
Indication: non-Small Cell Lung Cancer Stage IV
Start date: 2011-03-24
Gemzar
Dosage: last dose on 01apr2011, dur: 9 days. interrupted on 13apr2011,resumed on 27apr11
Indication: non-Small Cell Lung Cancer Stage IV
Start date: 2011-03-24
Necitumumab
Dosage: necitumumab liqiud 24mar2011-01apr2011(9 days) interrupted on 13apr2011,resumed on 27apr11
Indication: non-Small Cell Lung Cancer Stage IV
Start date: 2011-03-24
Other drugs received by patient: Bisoprolol; Permixon; Procodin; Simvastatin; Corticosteroid; Plavix; Ventolin
Possible Gemzar side effects in female
Reported by a physician from Japan on 2011-10-24
Patient: female, weighing 52.0 kg (114.4 pounds)
Reactions: White Blood Cell Count Decreased, Anaemia, Platelet Count Decreased, Intestinal Obstruction, Erythropenia, Ovarian Cancer
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Doxorubicin HCL
Start date: 2009-08-05
End date: 2009-08-05
Doxorubicin HCL
Start date: 2009-05-27
End date: 2009-05-27
Doxorubicin HCL
Start date: 2009-06-26
End date: 2009-06-26
Doxorubicin HCL
Doxorubicin HCL
Start date: 2009-09-02
End date: 2009-09-02
Doxorubicin HCL
Indication: Ovarian Cancer Recurrent
Doxorubicin HCL
Start date: 2009-10-13
End date: 2009-10-13
Doxorubicin HCL
Start date: 2010-01-01
End date: 2010-01-01
Doxorubicin HCL
Start date: 2010-01-01
End date: 2010-01-01
Doxorubicin HCL
Start date: 2009-04-28
End date: 2009-04-28
Gemzar
Indication: Ovarian Cancer Recurrent
Start date: 2008-10-29
Oxaliplatin
Indication: Ovarian Cancer Recurrent
Start date: 2008-10-01
Other drugs received by patient: Pydoxal; Primperan TAB; TPN; Celecoxib; Motilium; TPN; DAI-Kenchu-TO; Concentrated Human RED Blood Cells; Lansoprazole; Gasmotin; Motilium; Dacarbazine; TPN; Concentrated Human RED Blood Cells; Primperan TAB; Primperan TAB; Concentrated Human RED Blood Cells; Neutrogin; Concentrated Human RED Blood Cells
Possible Gemzar side effects in female
Reported by a physician from Japan on 2011-10-18
Patient: female, weighing 57.0 kg (125.4 pounds)
Reactions: White Blood Cell Count Decreased, RED Blood Cell Count Decreased, Neutrophil Count Decreased, Disease Progression
Adverse event resulted in: death
Drug(s) suspected as cause:
Carboplatin
Indication: Ovarian Cancer Recurrent
Start date: 2009-10-02
Doxorubicin HCL
Dosage: cycle 4
Indication: Ovarian Cancer Recurrent
Start date: 2009-11-20
End date: 2009-11-20
Doxorubicin HCL
Dosage: cycle 2
Start date: 2009-08-21
End date: 2009-08-21
Doxorubicin HCL
Dosage: cycle 1
Start date: 2009-07-24
End date: 2009-07-24
Doxorubicin HCL
Dosage: cycle 3
Start date: 2009-09-18
End date: 2009-09-18
Doxorubicin HCL
Dosage: cycle 4
Start date: 2009-10-19
End date: 2009-10-19
Gemzar
Indication: Ovarian Cancer Recurrent
Start date: 2009-06-12
Oxaliplatin
Indication: Ovarian Cancer Recurrent
Start date: 2009-06-12
End date: 2009-09-04
Other drugs received by patient: Cefazolin Sodium; Celecoxib; Herceptin; Neutrogin; Lansoprazole; Pydoxal; Unknown Medication; Itraconazole
Possible Gemzar side effects in male
Reported by a physician from Japan on 2011-10-14
Patient: male, weighing 65.0 kg (143.0 pounds)
Reactions: White Blood Cell Count Decreased, Cancer Pain, Recall Phenomenon, Generalised Oedema, Renal Impairment, Diarrhoea, Platelet Count Decreased, Ureteric Cancer Recurrent, Neutropenia, Bronchiolitis, Deep Vein Thrombosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Gemzar
Dosage: 1300 mg, day 1, 8, 15
Indication: Ureteric Cancer
Start date: 2010-01-06
End date: 2010-02-01
Gemzar
Dosage: 1300 mg, day 1, 8, 15
Start date: 2010-12-13
End date: 2011-03-01
Other drugs received by patient: Cisplatin; Cisplatin
|
